Medical Devices Startups
6,372 companies tagged Medical Devices, with their investors and founders.
Quadrant Eye develops at-home diagnostic technology to conduct comprehensive eye examinations. The platform aims to increase access to eye care services and help prevent avoidable vision loss.
2 investors
QualisureDx develops diagnostic tests using machine-learning and molecular analysis to identify unique cancer properties and guide personalized treatment decisions for oncologists. The company serves cancer care teams seeking to match patients with appropriate therapies that maximize efficacy while minimizing toxicity.
2 investors
QUE Oncology develops Q-122, a non-hormonal therapeutic candidate in clinical development for treating vasomotor symptoms in postmenopausal women and cancer patients on hormone therapy. The company was formed as a joint venture between Emory University and University of Queensland's commercialization entity.
2 investors
Qurcan develops veterinary pharmaceutical technology, with leadership holding advanced degrees in veterinary medicine, pharmaceutical sciences, and business development.
2 investors
Qure.ai builds deep learning and AI software to detect and manage diseases such as lung cancer, tuberculosis, pediatric TB, and stroke, with several FDA-cleared solutions. It serves clinicians and care teams as well as the pharmaceutical and medical device industries worldwide.
2 investors
QurieGen develops QuRIE-seq, a single-cell multi-omics platform that captures time-resolved single-cell data and trains lab-in-the-loop AI Virtual Cell models to predict cellular behavior and drug response. Spun out of the Huck Lab at Radboud University, the company serves pharmaceutical drug discovery and R&D.
2 investors
Qvin develops the Q-Pad, an FDA-cleared diagnostic menstrual pad that collects menstrual blood samples for non-invasive health monitoring and disease diagnosis. The company uses biomarker analysis from menstrual fluid to serve healthcare organizations and diagnostic platforms in women's health diagnostics.
2 investors
Radformation develops automation software for radiation oncology, including tools for deep-learning contouring, treatment planning, plan evaluation, independent calculations, treatment monitoring, billing QA, and machine QA. Its products integrate with Eclipse TPS and serve cancer clinics and medical physicists to improve plan quality, safety, and workflow efficiency.
2 investors
Radialis develops the Radialis PET Imager, an organ-targeted positron emission tomography system for high-resolution medical imaging of specific tissues and organs. The system is designed for use by healthcare providers in clinical settings to support cancer detection, treatment planning, and precision medicine applications.
2 investors
Radiant Biotherapeutics develops a platform of therapeutic molecules called Multabodies that engage multiple disease targets simultaneously within a single engineered protein to treat cancer and infectious diseases.
2 investors
RADiCAIT develops Insilico PET, an AI-powered technology that transforms routine CT scans into functional disease activity maps without requiring radioactive tracers or additional hardware, enabling faster and more accessible diagnostic imaging at scale.
2 investors
Radiology Partners is a physician-led national radiology practice that provides diagnostic imaging services and develops AI tools and technology to support radiologists in delivering patient care. It serves patients, referring physicians, and healthcare clients across the United States.
2 investors
RadioNano Therapeutics develops boron neutron capture therapy (BNCT), an advanced radiotherapy targeting cancer cells. The company is commercializing RN-501, a nanoparticle-enhanced therapeutic drug aimed at improving treatment safety and efficacy for cancer patients.
2 investors
Radionetics develops small molecule radiopharmaceuticals targeting GPCRs for cancer therapy and diagnosis, using a precision medicine approach that combines radioisotopes with potent, selective ligands. The company is headquartered in San Diego, California, and focuses on theranostic applications in oncology.
2 investors
Ramp USA makes customizable wheelchairs designed for comfort and independence, built for both on-road and off-road use. Customers can work with the company's team to configure a chair to fit their needs.
2 investors
RapidPulse Medical is an investor relations page showcasing multiple healthcare-focused investment firms and incubators that back medical device and healthcare technology companies.
2 investors
Rapport is a biopharmaceutical company developing novel therapeutics. The company is led by a team with extensive experience in drug discovery, clinical development, and commercialization across neuroscience and rare disease indications.
2 investors
RareCan provides cancer treatment and clinical trial access tailored to individual patients, with a focus on improving outcomes for people diagnosed with rare cancers.
2 investors
Rarity Bioscience develops superRCA, a molecular detection technology that identifies DNA mutations with exceptional sensitivity for precision medicine applications. The company commercializes diagnostic assays and kits for clinical and research settings, with initial focus on leukemia and cancer detection.
2 investors
Rebel Medicine develops preclinical investigational drugs and wound care products designed to provide pain relief without opioids. The company targets postoperative and wound care patients through patented drug delivery technologies for local anesthetic applications.
2 investors
ReBio develops targeted, locally delivered therapies for ocular oncology, using its proprietary SiSu conjugate platform to program drug exposure for eye diseases. Its lead program, RBP-01, is a SiSu-conjugated PKC inhibitor for uveal melanoma delivered via intravitreal injection, with additional programs targeting retinoblastoma, glaucoma, and post-op ocular inflammation.
2 investors
Recor Medical develops the Paradise Ultrasound Renal Denervation system, a therapy that uses ultrasound technology to lower blood pressure in patients with hypertension. Founded in 2009 and now part of Otsuka Medical Devices, the company brings its hypertension treatment to physicians and patients worldwide.
2 investors
Red Arrow Therapeutics develops cancer therapies using a proprietary nanopolymer drug-delivery system for programmable encapsulation and release of biologics such as peptides, antibodies, and proteins. It aims to build a pipeline of polymer-drug conjugate cancer drugs with targeted tumor delivery and reduced off-tumor toxicity.
2 investors
RedDrop Dx makes a capillary blood collection device for virtually pain-free, one-click sampling that produces higher blood volume and reliable samples. The product uses 1mL tubes designed for high-throughput labs and is aimed at patients, providers, and lab partners in healthcare.
2 investors